rs934806813

Variant summary

Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BP4_StrongBS2

The ENST00000377387.5(SF1):​c.389C>T​(p.Pro130Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000022 in 999,154 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.000027 ( 0 hom., cov: 31)
Exomes 𝑓: 0.000021 ( 0 hom. )

Consequence

SF1
ENST00000377387.5 missense

Scores

1
1
14

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: -0.277

Publications

0 publications found
Variant links:
Genes affected
SF1 (HGNC:12950): (splicing factor 1) This gene encodes a nuclear pre-mRNA splicing factor. The encoded protein specifically recognizes the intron branch point sequence at the 3' splice site, together with the large subunit of U2 auxiliary factor (U2AF), and is required for the early stages of spliceosome assembly. It also plays a role in nuclear pre-mRNA retention and transcriptional repression. The encoded protein contains an N-terminal U2AF ligand motif, a central hnRNP K homology motif and quaking 2 region which bind a key branch-site adenosine within the branch point sequence, a zinc knuckles domain, and a C-terminal proline-rich domain. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2016]
SF1-DT (HGNC:55278): (SF1 divergent transcript)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -8 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.05879444).
BS2
High AC in GnomAdExome4 at 18 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SF1NM_004630.4 linkc.31+358C>T intron_variant Intron 1 of 12 ENST00000377390.8 NP_004621.2 Q15637-1A0A024R572

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SF1ENST00000377390.8 linkc.31+358C>T intron_variant Intron 1 of 12 1 NM_004630.4 ENSP00000366607.3 Q15637-1

Frequencies

GnomAD3 genomes
AF:
0.0000272
AC:
4
AN:
146866
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000195
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000303
Gnomad OTH
AF:
0.00
GnomAD4 exome
AF:
0.0000211
AC:
18
AN:
852288
Hom.:
0
Cov.:
29
AF XY:
0.0000101
AC XY:
4
AN XY:
395682
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
16084
American (AMR)
AF:
0.00
AC:
0
AN:
1642
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
5614
East Asian (EAS)
AF:
0.00
AC:
0
AN:
4372
South Asian (SAS)
AF:
0.00
AC:
0
AN:
17478
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
2180
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
1718
European-Non Finnish (NFE)
AF:
0.0000142
AC:
11
AN:
774750
Other (OTH)
AF:
0.000246
AC:
7
AN:
28450
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.478
Heterozygous variant carriers
0
2
3
5
6
8
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000272
AC:
4
AN:
146866
Hom.:
0
Cov.:
31
AF XY:
0.0000420
AC XY:
3
AN XY:
71434
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
40942
American (AMR)
AF:
0.00
AC:
0
AN:
14776
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3392
East Asian (EAS)
AF:
0.000195
AC:
1
AN:
5140
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4820
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
8546
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
312
European-Non Finnish (NFE)
AF:
0.0000303
AC:
2
AN:
66004
Other (OTH)
AF:
0.00
AC:
0
AN:
2022
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.425
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000142
Hom.:
0
Bravo
AF:
0.0000264

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Mar 07, 2023
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.389C>T (p.P130L) alteration is located in exon 1 (coding exon 1) of the SF1 gene. This alteration results from a C to T substitution at nucleotide position 389, causing the proline (P) at amino acid position 130 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
-0.22
T
BayesDel_noAF
Benign
-0.56
CADD
Benign
14
DANN
Benign
0.97
Eigen
Benign
-0.81
Eigen_PC
Benign
-0.87
FATHMM_MKL
Benign
0.051
N
LIST_S2
Benign
0.42
T
M_CAP
Uncertain
0.26
D
MetaRNN
Benign
0.059
T
MetaSVM
Benign
-1.0
T
PhyloP100
-0.28
PrimateAI
Pathogenic
0.81
D
PROVEAN
Benign
0.54
N
REVEL
Benign
0.043
Sift
Benign
0.14
T
Sift4G
Benign
0.35
T
Polyphen
0.22
B
Vest4
0.10
MutPred
0.16
Gain of MoRF binding (P = 0.0633);
MVP
0.18
MPC
1.7
ClinPred
0.41
T
GERP RS
-0.59
PromoterAI
0.11
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
gMVP
0.075
Mutation Taster
=93/7
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs934806813; hg19: chr11-64545476; API